{
    "nct_id": "NCT04087980",
    "official_title": "Multicenter Pilot Study of the Poseidon System for the Ablation of Prostate Tissue Utilizing Sterile Water Vapor in Patients With Intermediate Risk Localized Prostate Cancer",
    "inclusion_criteria": "* 45-80 years old\n* Biopsy confirmed unilateral, adenocarcinoma of the prostate\n* Minimum of 12 biopsy cores obtained ≥4 weeks and ≤12 months before treatment. Targeted fusion biopsy is preferred if there is a MRI PI-RADs ≥3 lesion. It is preferred a standard 12 sector biopsy is mapped. MRI required if biopsy was completed >6 months prior to treatment date to confirm no MRI progression of disease that would be considered exclusionary.\n* ≤4 of 6 standard sector biopsy cores positive for prostate cancer (unilateral); positive core(s) from a targeted lesion count as one positive core.\n* Gleason score of 7 (3+4) / International Society of Urological Pathologists (ISUP) Gleason Grade Group (GGG) 2\n* Clinical Stage less than or equal to T2b N0 M0\n* PSA (Prostate Specific Antigen) less than or equal to 15ng/mL\n* Prostate size 20-80cc\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 45 Years\nMust have maximum age of 80 Years",
    "exclusion_criteria": "* Malignant tumors identified by extraprostatic extension, sphincter involvement/lesion abutment seminal vesicle invasion or lymph node invasion or metastasis\n* Narrow Peripheral Zone\n* MRI identified PI-RADs ≥4 lesion contralateral to the side that has biopsy confirmed adenocarcinoma\n* Prior definitive treatment of prostate cancer",
    "miscellaneous_criteria": ""
}